Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +6
  • Study of CD7-CART01, Cyclophosphamide, and Fludarabine Phosphate for Children and Young Adults with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

    Recruiting

    2 1 1 1
    Italy
  • Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

    Recruiting

    3 1
    Czechia Denmark France Germany Greece Italy +4
  • Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +5
  • Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Germany Italy Poland +2
  • Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Bulgaria Croatia France Germany Hungary +6
  • Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany
  • Efficacy and safety of oral venglustat versus intravenous imiglucerase in children aged 2‑11 years with Gaucher disease type 3

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Finland France Germany Hungary
  • Study of dimethyl fumarate safety and efficacy in patients with Neurodegeneration with Brain Iron Accumulation (NBIA), including PKAN and MPAN

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Poland
  • Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland